RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Emerging public health law and policy issues concerning state medical cannabis programs
Tilburg, W. C., Hodge, J. G., & Gourdet, C. (2019). Emerging public health law and policy issues concerning state medical cannabis programs. Journal of Law Medicine & Ethics, 47(2_suppl), 108-111. https://doi.org/10.1177/1073110519857331
Thirty-four states, the District of Columbia, and Puerto Rico have legalized medical cannabis. While no two state medical cannabis programs are alike, public health concerns related to advertising, packaging and labeling, pesticide use, scientific research, and the role of medical cannabis in the opioid crisis are emerging across the country. This article examines these issues, the policy approaches states are adopting to protect patients and the public, and an assessment of the underlying federal legal landscape.
